Cargando…
A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenario
BACKGROUND: Non-Hodgkin lymphomas (NHL) are the most frequent hemato-oncological malignancies. Despite recent major advances in treatment, a substantial proportion of patients relapses highlighting the need for new therapeutic modalities. Promissory results obtained in pre-clinical studies are usual...
Autores principales: | Bascuas, Thais, Moreno, María, Mónaco, Amy, Reyes, Laura, Paolino, Andrea, Oliver, Patricia, Kramer, María G., Engler, Henry, Pacheco, José P., Grille, Sofía, Chabalgoity, José A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118904/ https://www.ncbi.nlm.nih.gov/pubmed/27876058 http://dx.doi.org/10.1186/s12967-016-1073-8 |
Ejemplares similares
-
Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice
por: Bascuas, Thais, et al.
Publicado: (2018) -
Salmonella Typhimurium Triggers Extracellular Traps Release in Murine Macrophages
por: Mónaco, Amy, et al.
Publicado: (2021) -
Hodgkin Lymphoma in People Living with HIV
por: Navarro, Jose-Tomas, et al.
Publicado: (2021) -
Tumor Size Measurements for Predicting Hodgkin’s and Non-Hodgkin’s Lymphoma Response to Treatment
por: Kallergi, Maria, et al.
Publicado: (2022) -
Salmonella-induced immune response reduces recurrence and tumor dissemination in preclinical melanoma model
por: Mónaco, Amy, et al.
Publicado: (2022)